NASDAQ : TGTX
TG Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 61.18 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 8.68B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
TG Therapeutics, Inc. (TGTX) reported revenue of 799.54M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 799.54M | 616.29M | 329.00M | 233.66M | 2.79M | 6.69M |
| Cost of Revenue | 140.94M | 100.71M | 38.49M | 14.13M | 265.00K | 790.00K |
| Gross Profit | 658.60M | 515.57M | 290.52M | 219.53M | 2.52M | 5.90M |
| Selling, General & Admin | 296.46M | 232.03M | 154.30M | 122.71M | 95.48M | 128.09M |
| Research & Development | 225.80M | 160.22M | 94.29M | 76.19M | 125.35M | 222.58M |
| Operating Expenses | 522.27M | 392.25M | 248.59M | 198.90M | 220.84M | 350.67M |
| Operating Income | 136.33M | 123.32M | 41.93M | 20.63M | -218.32M | -344.77M |
| Interest Expense | -37.49M | -26.73M | -24.03M | -12.62M | -10.19M | -5.64M |
| Other Non Operating Income (Expenses) | 11.92M | 10.79M | 7.69M | 5.04M | 4.70M | 2.31M |
| Pretax Income | 101.60M | 107.39M | 25.59M | 13.06M | -223.81M | -348.10M |
| Income Tax Expense | -339.89M | -339.79M | 2.21M | 390.00K | ||
| Net Income | 441.49M | 447.18M | 23.38M | 12.67M | -223.81M | -348.10M |
| Net Income to Common | 441.49M | 447.18M | 23.38M | 12.67M | -223.81M | -348.10M |
| Shares Outstanding (Basic) | 142.51M | 144.32M | 145.32M | 141.96M | 135.41M | 132.22M |
| Shares Outstanding (Diluted) | 159.48M | 161.41M | 160.34M | 148.51M | 135.41M | 132.22M |
| EPS (Basic) | 3.10 | 3.10 | 0.16 | 0.09 | -1.65 | -2.63 |
| EPS (Diluted) | 2.77 | 2.77 | 0.15 | 0.09 | -1.65 | -2.63 |
| Free Cash Flow | 17.39M | -24.99M | -40.56M | -31.41M | -176.18M | -296.04M |
| Free Cash Flow Per Share | 0.11 | -0.15 | -0.25 | -0.21 | -1.30 | -2.24 |
| Gross Margin | 82.37% | 83.66% | 88.30% | 93.95% | 90.48% | 88.19% |
| Operating Margin | 17.05% | 20.01% | 12.74% | 8.83% | -7,838.99% | -5,154.28% |
| Profit Margin | 55.22% | 72.56% | 7.11% | 5.42% | -8,036.34% | -5,204.08% |
| Free Cash Flow Margin | 2.17% | -4.05% | -12.33% | -13.44% | -6,326.18% | -4,425.70% |
| EBITDA | 136.45M | 123.38M | 42.00M | 20.84M | -218.01M | -344.49M |
| EBITDA Margin | 17.07% | 20.02% | 12.77% | 8.92% | ||
| D&A For EBITDA | 123.00K | 59.00K | 68.00K | 211.00K | 303.00K | 282.00K |
| EBIT | 136.33M | 123.32M | 41.93M | 20.63M | -218.32M | -344.77M |
| EBIT Margin | 17.05% | 20.01% | 12.74% | 8.83% | ||
| Effective Tax Rate | 8.64% | 2.99% | ||||
| Revenue as Reported | 799.54M | 616.29M | 329.00M | 233.66M | 2.79M | 6.69M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 482.57M | 79.15M | 179.89M | 92.93M | 102.30M | 298.89M |
| Short-Term Investments | 69.67M | 62.82M | 131.11M | 124.58M | 59.37M | 15.88M |
| Cash & Short-Term Investments | 552.25M | 141.97M | 311.00M | 217.51M | 161.68M | 314.76M |
| Accounts Receivable | 401.56M | 305.63M | 129.19M | 51.09M | 1.39M | |
| Receivables | 401.56M | 305.63M | 129.19M | 51.09M | 1.39M | |
| Inventory | 147.97M | 125.59M | 110.46M | 39.82M | ||
| Other Current Assets | 43.90M | 57.58M | 15.72M | 9.52M | 6.60M | 14.81M |
| Total Current Assets | 1.15B | 630.76M | 566.36M | 317.94M | 168.27M | 330.96M |
| Property, Plant & Equipment | 7.08M | 6.28M | 7.15M | 8.05M | 9.20M | 9.23M |
| Long-Term Investments | 64.37M | 59.14M | 808.00K | 12.40M | 35.53M | |
| Goodwill | 799.00K | 799.00K | ||||
| Long-Term Deferred Tax Assets | 343.43M | 348.00M | ||||
| Long-Term Deferred Charges | 1.63M | 1.84M | ||||
| Other Long-Term Assets | 79.06M | 19.07M | 3.37M | 3.59M | 1.27M | 1.26M |
| Total Assets | 1.64B | 1.06B | 577.69M | 329.59M | 193.57M | 379.63M |
| Accounts Payable | 120.09M | 47.41M | 37.40M | 29.27M | 42.02M | 50.89M |
| Accrued Expenses | 59.51M | 41.05M | 15.19M | 12.17M | 8.43M | 10.17M |
| Current Portion of Long-Term Debt | 689.00K | 661.00K | 357.00K | 243.00K | 1.33M | |
| Current Portion of Leases | 1.91M | 1.04M | 1.16M | 1.45M | 1.58M | 1.44M |
| Current Unearned Revenue | 16.82M | 21.23M | 11.41M | 152.00K | 200.00K | |
| Other Current Liabilities | 70.16M | 42.34M | 24.87M | 10.32M | 926.00K | 1.35M |
| Total Current Liabilities | 268.49M | 153.76M | 90.68M | 53.72M | 53.20M | 65.38M |
| Long-Term Debt | 745.39M | 245.65M | 244.43M | 100.12M | 71.14M | 66.79M |
| Long-Term Leases | 7.14M | 7.02M | 8.13M | 9.23M | 10.34M | 9.85M |
| Long-Term Unearned Revenue | 14.53M | 8.81M | 12.09M | 6.02M | 305.00K | 457.00K |
| Total Liabilities | 1.04B | 415.23M | 355.33M | 169.09M | 134.99M | 142.48M |
| Common Stock | 160.00K | 159.00K | 156.00K | 151.00K | 146.00K | 143.00K |
| Additional Paid-In Capital | 1.86B | 1.83B | 1.76B | 1.71B | 1.59B | 1.57B |
| Retained Earnings | -1.05B | -1.08B | -1.53B | -1.55B | -1.53B | -1.33B |
| Treasury Stock | -200.23M | -100.23M | -8.99M | -234.00K | -234.00K | -234.00K |
| Shareholders' Equity | 604.08M | 648.02M | 222.36M | 160.50M | 58.59M | 237.15M |
| Total Liabilities & Equity | 1.64B | 1.06B | 577.69M | 329.59M | 193.57M | 379.63M |
| Total Debt | 754.44M | 254.40M | 254.38M | 111.15M | 83.30M | 79.41M |
| Net Cash (Debt) | -202.19M | -112.43M | 56.62M | 106.36M | 78.38M | 235.36M |
| Net Cash Per Share | -1.27 | -0.70 | 0.35 | 0.72 | 0.58 | 1.78 |
| Filing Date Shares Outstanding | 141.85M | 147.68M | 145.23M | 144.78M | 137.63M | 130.79M |
| Total Common Shares Outstanding | 141.86M | 143.29M | 143.99M | 141.79M | 137.65M | 131.22M |
| Working Capital | 877.19M | 477.00M | 475.68M | 264.22M | 115.07M | 265.58M |
| Book Value Per Share | 4.26 | 4.52 | 1.54 | 1.13 | 0.43 | 1.81 |
| Tangible Book Value | 604.08M | 648.02M | 222.36M | 160.50M | 57.79M | 236.35M |
| Tangible Book Value Per Share | 4.26 | 4.52 | 1.54 | 1.13 | 0.42 | 1.80 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 441.49M | 447.18M | 23.38M | 12.67M | -223.81M | -348.10M |
| Depreciation & Amortization | 123.00K | 59.00K | 68.00K | 211.00K | 303.00K | 282.00K |
| Other Amortization | 1.32M | 1.40M | 2.21M | 2.59M | 2.06M | 1.29M |
| Loss (Gain) From Sale of Investments | -4.54M | -3.49M | -6.23M | -2.24M | -331.00K | 517.00K |
| Stock-Based Compensation | 81.16M | 64.67M | 42.54M | 37.93M | 44.66M | 61.27M |
| Other Operating Activities | -325.74M | -340.05M | 6.81M | 2.08M | 2.60M | 1.32M |
| Change in Accounts Receivable | -170.05M | -176.44M | -78.09M | -51.09M | 1.39M | -1.39M |
| Change in Inventory | -70.84M | -33.45M | -66.85M | -36.94M | ||
| Change in Accounts Payable | 81.82M | 55.88M | 22.84M | 192.00K | -11.01M | 15.99M |
| Change in Unearned Revenue | 5.77M | 6.39M | 17.48M | 5.71M | -152.00K | -152.00K |
| Change in Other Net Operating Assets | -12.07M | -46.91M | -4.67M | -2.53M | 8.13M | -26.67M |
| Operating Cash Flow | 17.88M | -24.77M | -40.52M | -31.41M | -176.17M | -295.63M |
| Capital Expenditures | -491.00K | -214.00K | -45.00K | -14.00K | -401.00K | |
| Investment in Securities | 22.38M | 14.01M | -991.00K | -50.65M | -20.00M | 69.00K |
| Investing Cash Flow | 21.89M | 13.80M | -1.04M | -50.65M | -20.01M | -332.00K |
| Long-Term Debt Issued | 244.81M | 25.00M | 70.00M | |||
| Long-Term Debt Repaid | -107.55M | -975.00K | -30.00M | |||
| Net Debt Issued (Repaid) | 492.66M | 137.26M | 25.00M | -975.00K | 40.00M | |
| Issuance of Common Stock | 1.91M | 1.51M | 914.00K | 47.83M | 584.00K | 2.44M |
| Repurchase of Common Stock | -178.23M | -91.24M | -8.76M | |||
| Other Financing Activities | -2.60M | -889.00K | -125.00K | -1.02M | ||
| Financing Cash Flow | 313.73M | -89.73M | 128.53M | 72.70M | -391.00K | 41.42M |
| Net Cash Flow | 353.50M | -100.70M | 86.97M | -9.36M | -196.57M | -254.55M |
| Free Cash Flow | 17.39M | -24.99M | -40.56M | -31.41M | -176.18M | -296.04M |
| Free Cash Flow Margin | 2.17% | -4.05% | -12.33% | -13.44% | -6,326.18% | -4,425.70% |
| Free Cash Flow Per Share | 0.11 | -0.15 | -0.25 | -0.21 | -1.30 | -2.24 |
| Levered Free Cash Flow | 59.13M | -43.98M | -62.02M | -47.55M | -97.44M | -166.60M |
| Unlevered Free Cash Flow | 81.43M | -28.49M | -49.00M | -42.05M | -92.91M | -164.16M |
| Cash Interest Paid | 32.67M | 24.25M | 18.47M | 8.77M | 5.45M | 3.47M |
| Cash Income Tax Paid | 14.12M | 7.88M | 500.00K | |||
| Change in Working Capital | -175.95M | -194.54M | -109.30M | -84.66M | -1.65M | -12.22M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 8.68B | 4.36B | 4.32B | 2.42B | 1.58B | 2.49B |
| Enterprise Value | 8.88B | 4.48B | 4.23B | 2.30B | 1.49B | 2.16B |
| Last Close Price | 61.18 | 29.81 | 30.10 | 17.08 | 11.83 | 19.00 |
| PE Ratio | 22.10 | 9.75 | 184.75 | 190.66 | ||
| Forward PE | 31.92 | 20.29 | 45.21 | 134.45 | ||
| PS Ratio | 10.85 | 7.07 | 13.13 | 10.34 | 568.84 | 371.96 |
| PB Ratio | 14.37 | 6.72 | 19.43 | 15.05 | 27.04 | 10.49 |
| P/TBV Ratio | 14.37 | 6.72 | 19.43 | 15.05 | 27.41 | 10.53 |
| PEG Ratio | 1.42 | 0.14 | 0.37 | |||
| EV/Sales Ratio | 11.11 | 7.27 | 12.87 | 9.83 | 535.24 | 322.82 |
| EV/EBITDA Ratio | 65.08 | 36.32 | 100.79 | 110.20 | ||
| EV/EBIT Ratio | 65.14 | 36.34 | 100.95 | 111.33 | ||
| Debt / Equity Ratio | 1.25 | 0.39 | 1.14 | 0.69 | 1.42 | 0.34 |
| Debt / EBITDA Ratio | 5.45 | 2.03 | 5.74 | 4.82 | ||
| Debt / FCF Ratio | 43.40 | |||||
| Net Debt / Equity Ratio | 0.34 | 0.17 | -0.26 | -0.66 | -1.34 | -0.99 |
| Net Debt / EBITDA Ratio | 1.48 | 0.91 | -1.35 | -5.10 | 0.36 | 0.68 |
| Net Debt / FCF Ratio | 11.63 | -4.50 | 1.40 | 3.39 | 0.45 | 0.80 |
| Asset Turnover | 0.68 | 0.75 | 0.72 | 0.89 | 0.01 | 0.01 |
| Inventory Turnover | 0.93 | 0.85 | 0.51 | |||
| Quick Ratio | 3.55 | 2.91 | 4.85 | 5.00 | 3.04 | 4.83 |
| Current Ratio | 4.27 | 4.10 | 6.25 | 5.92 | 3.16 | 5.06 |
| Return on Equity (ROE) | 100.28% | 102.75% | 12.21% | 11.57% | -151.36% | -92.03% |
| Return on Assets (ROA) | 7.28% | 9.39% | 5.78% | 4.93% | -47.61% | -42.87% |
| Return on Invested Capital (ROIC) | 16.74% | 26.63% | 34.84% | 36.97% | ||
| Return on Capital Employed (ROCE) | 9.90% | 13.60% | 8.60% | 7.50% | -155.50% | -109.70% |
| Earnings Yield | 4.52% | 10.26% | 0.54% | 0.52% | -14.13% | -13.99% |
| FCF Yield | 0.20% | -0.57% | -0.94% | -1.30% | -11.12% | -11.90% |
| Buyback Yield / Dilution | 5.56% | -0.67% | -7.96% | -9.67% | -2.41% | -14.64% |